[Nephrotic syndrome and acute pancreatitis related to glucantime administration].
Valencia
M E
ME
Laguna
F
F
González Lahoz
J
J
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000208:Acute Disease; D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000965:Antimony / Q000009:adverse effects*; D000981:Antiprotozoal Agents / Q000009:adverse effects*; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000188:drug therapy*; D008297:Male; D008536:Meglumine / Q000009:adverse effects*; D000077485:Meglumine Antimoniate; D009404:Nephrotic Syndrome / Q000139:chemically induced*; D009942:Organometallic Compounds / Q000009:adverse effects*; D010195:Pancreatitis / Q000139:chemically induced*
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate; D000666:Amphotericin B; D000965:Antimony